Elizabeth A. Repasky

Roswell Park Comprehensive Cancer Center — United States

Medicine · Health Sciences

60h-index12.6kcitations378works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Stress, Anesthesia, and Immune Response(97), Cancer Immunotherapy and Biomarkers(57), Heat shock proteins research(49), Immunotherapy and Immune Responses(42), Immune Cell Function and Interaction(38)

Publications375 total

Development and External Validation of Integrated Machine Learning-Based Prognostic Model in Oropharyngeal Head and Neck Cancer Using the Systemic Inflammatory Response Index
Cancers·2025Open Access
A Novel Chaperone-Based Cancer Vaccination Enhances Immunotherapeutic Responsiveness Through T Cell Amplification and Tumor Immune Remodeling
Vaccines·2025Open Access
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma
Cancer Cell·2025· 4 citedOpen Access
Sex parity in stimulation of murine lymphocyte trafficking in response to fever-range systemic thermal therapy
International Journal of Hyperthermia·2025Open Access
Comprehensive molecular and immune characterization of adrenergic stress-signaling receptor <i>ADRB2</i> in triple negative breast cancer (TNBC).
Journal of Clinical Oncology·2025
A phase Il trial to assess the impact of β2 adrenergic receptor (β2-AR) blockade in metastatic triple negative breast cancer (mTNBC).
Journal of Clinical Oncology·2025
Chronic rejection models for vascularized composite tissue allotransplantation
Scientific Reports·2025· 4 citedOpen Access
Prognostic immune markers in esophageal cancer patients managed with trimodal therapy
Cancer Immunology Immunotherapy·2025· 1 citedOpen Access
Obesity-Mediated Intratumoral Innervation Increases Pancreatic Cancer Tumorigenesis
SSRN Electronic Journal·2025Open Access
Stress biology: Complexity and multifariousness in health and disease
UNC Libraries·2024Open Access
Integrating priorities at the intersection of cancer and neuroscience
Cancer Cell·2024· 19 citedOpen Access
Prognostic Immune Markers in Esophageal Cancer Patients Managed with Trimodal Therapy
International Journal of Radiation Oncology*Biology*Physics·2024
Temperature matters: the potential impact of thermoregulatory mechanisms in brain–body physiology
Genes & Development·2024· 3 citedOpen Access
Exportin 1 governs the immunosuppressive functions of myeloid-derived suppressor cells in tumors through ERK1/2 nuclear export
Cellular and Molecular Immunology·2024· 16 citedOpen Access
A phase II trial to assess the impact of β2 adrenergic blockade in immune checkpoint inhibitor (ICI)– refractory metastatic triple negative breast cancer (mTNBC).
Journal of Clinical Oncology·2024
Next Directions in the Neuroscience of Cancers Arising outside the CNS
Cancer Discovery·2024· 36 citedOpen Access
Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies
Nature Communications·2024· 30 citedOpen Access
Abstract 105: Understanding the role of β2-adrenergic receptor signaling on type II innate lymphoid cells in cancer
Cancer Research·2024
Stress biology: Complexity and multifariousness in health and disease
Cell Stress and Chaperones·2024· 6 citedOpen Access
Editorial: A new chapter for Cell Stress and Chaperones
Cell Stress and Chaperones·2024Open Access
page 1 of 19Next →

Frequent Co-authors

Bonnie L. Hylander(15), John R. Subjeck(9), Sharon S. Evans(8), Julie R. Ostberg(7), Kathleen M. Kokolus(6), Guanxi Qiao(6), Mark J. Bucsek(6), Hemn Mohammadpour(5), Minhui Chen(5), Chen-Ting Lee(4), Jason W.‐L. Eng(4), Scott I. Abrams(4), Cameron R. MacDonald(4), Xiangyang Wang(4), Masoud H. Manjili(4), Thomas A. Mace(4), Maegan L. Capitano(3), Xing Chen(3), Robert Henderson(3), Lingwen Zhong(3)